Neil Chatterji
Stock Analyst at B. Riley Securities
(1.15)
# 3,507
Out of 4,843 analysts
17
Total ratings
26.67%
Success rate
-0.15%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $15 → $20 | $11.86 | +68.63% | 2 | Jan 28, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $12.16 | +6.95% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $34.39 | +45.39% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.53 | +390.20% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $12.56 | +43.31% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $2.74 | +64.23% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.60 | +480.91% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.14 | +157.01% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $2.40 | +295.83% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Jan 28, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $11.86
Upside: +68.63%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $12.16
Upside: +6.95%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $34.39
Upside: +45.39%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.53
Upside: +390.20%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $12.56
Upside: +43.31%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $2.74
Upside: +64.23%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.60
Upside: +480.91%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.14
Upside: +157.01%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $2.40
Upside: +295.83%